Cingulate Inc. - Common Stock (CING)

Cingulate Inc is a biopharmaceutical company focused on developing innovative treatments for patients with attention-related disorders, particularly attention deficit hyperactivity disorder (ADHD)

The company's expertise lies in creating unique formulations that aim to improve medication adherence and enhance therapeutic outcomes for individuals affected by these conditions. Through advanced drug delivery systems and proprietary technologies, Cingulate is committed to addressing unmet medical needs and providing healthcare professionals with effective therapeutic options tailored to the complexities of ADHD.